Sign in
4

Changes in Ownership

Outlook Therapeutics, Inc. Filed Acc 0001649989-26-000002

Director bought 5,000 shares at $0.43 ($2,145)

From the SEC's structured data for this filing

Trades in this filing

THURMAN RANDY H · Director

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2026-05-26 Purchase : show line 1 in the form +5,000 $0.43 $2,145 5,593 D
Open-market purchases · 5,000 sh · avg $0.43 · $2,145
Loading xslF345X06/primary_doc.xml…